share_log

Morgan Stanley Maintains Equal-Weight on Graphite Bio, Lowers Price Target to $3

Morgan Stanley Maintains Equal-Weight on Graphite Bio, Lowers Price Target to $3

摩根士丹利对Graphite Bio维持同等权重,将目标股价下调至3美元
Benzinga Real-time News ·  2023/02/03 08:24

Morgan Stanley analyst Jeffrey Hung maintains Graphite Bio (NASDAQ:GRPH) with a Equal-Weight and lowers the price target from $6 to $3.

摩根士丹利分析师杰弗里·洪维持Graphite Bio(纳斯达克股票代码:GRPH)的权重相等,并将目标股价从6美元下调至3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发